Pasar al contenido principal

CARACTERIZACION Y MODULACION DEL EJE TRIBBLES/AKT/FOXO EN MELANOMA (TAFMELANOMA)

PID2022-136654OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

FOXO family isoforms

  • Santos, Bruno
  • Grenho, Inês
  • Martel, Paulo J.
  • Ferreira, Bibiana I.
  • Link, Wolfgang
FOXO family of proteins are transcription factors involved in many physiological and pathological processes including cellular homeostasis, stem cell maintenance, cancer, metabolic, and cardiovascular diseases. Genetic evidence has been accumulating to suggest a prominent role of FOXOs in lifespan regulation in animal systems from hydra, C elegans, Drosophila, and mice. Together with the observation that FOXO3 is the second most replicated gene associated with extreme human longevity suggests that pharmacological targeting of FOXO proteins can be a promising approach to treat cancer and other age-related diseases and extend life and health span. However, due to the broad range of cellular functions of the FOXO family members FOXO1, 3, 4, and 6, isoform-specific targeting of FOXOs might lead to greater benefits and cause fewer side effects. Therefore, a deeper understanding of the common and specific features of these proteins as well as their redundant and specific functions in our cells represents the basis of specific targeting strategies. In this review, we provide an overview of the evolution, structure, function, and disease-relevance of each of the FOXO family members., This work was supported by the Spanish Ministry of Science, Innovation and Universities through grant RTI2018-094629-B-I00 to W.L., and Fundação para a Ciência e Tecnologia—FCT (PTDC/MED-ONC/4167/2020) and Algarve Biomedical Center (ABC) to B.I.F. and by STRATAGEM COST Action, CA17104. This work was supported by a grant from Spanish Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación and the European Regional Development Fund (PID2022-136654OB-I00 financed by MCIN/AEI /10.13039/501100011033 / FEDER, UE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal Cancer

  • Masci, Domiziana
  • Ling, Lele
  • Yang, Lian
  • Puxeddu, Michela
  • Colla, Claudia
  • Coluccia, Antonio
  • Santelli, Martina
  • Sciò, Pietro
  • Cuřínová, Petra
  • Ansari, Mohammad Salik Zeya
  • Naro, Chiara
  • Sette, Claudio
  • Jiménez, Lucía
  • Link, Wolfgang
  • Bigogno, Chiara
  • Dondio, Giulio
  • Hamel, Ernest
  • Liu, Te
  • Silvestri, Romano
  • La Regina, Giuseppe
Ferroptosis-inducing agents are an emerging class of nonapoptotic, iron-dependent compounds for anticancer chemotherapy. We describe the synthesis of new aroyl diheterocyclyl pyrrole derivatives 2–21. Compound 12 exhibited the most potent in vitro anticancer activity against breast cancer (BC), triple-negative breast cancer (TNBC), and colorectal cancer (CRC) cell lines, as well as significant efficacy in an HCT116 CRC xenograft model. Compound 12 showed typical hallmarks of ferroptosis in HCT116 cells from tumor tissues both in immunofluorescence and a qPCR gene assay and in the expression of ferroptosis inhibited proteins. Compound 12 significantly lowered GSH, NADP+, and NADPH levels. Furthermore, lactoperoxidase, malondialdehyde, and Fe(II) levels significantly increased in 12-treated tissues, whereas superoxide dismutase concentrations decreased. Taken together, these results indicate that the antitumor activity of compound 12 was caused by the strong induction of ferroptosis. Given its high activity, compound 12 represents a promising therapeutic candidate for TNBC and CRC, This research was supported in part by the Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the National Cancer Institute, which includes federal funds under Contract No. HHSN261200800001E. The authors thank the financial support of AIRC-IG 2020, code no. 24703, to R.S.; the Sapienza University of Rome RG11816428A9B4D5 and RM120172A7EAD07C to R.S.; RG123188B4D193AE and RM12218167FD3A37 to G.L.R.; RG120172AD61BE52 to A.C.; MUR PRIN 2022 2022TPPNTK (European Union-Next Generation EU) to G.L.R.; and Progetti di Avvio alla Ricerca to M.P. This work was supported by the Università Cattolica del Sacro Cuore (Linea D1) and the Italian Ministry of Health (Ricerca Corrente 2022 to Fondazione Policlinico A. Gemelli IRCCS). This work was supported by a grant from the Spanish Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación and the European Regional Development Fund (PID2022-136654OB-I00 financed by MCIN/AEI/10.13039/501100011033/FEDER, UE). This work was supported by a Special project for traditional Chinese medicine and clinical evaluation platform of traditional Chinese medicine (No. A1-U21-205-01010202) for T.L., Peer reviewed